As was shown recently, one of the plasma glycation sites (namely K141 in haptoglobin) might provide an additional diagnostic tool in combination with well-established T2DM markers, such as fasting plasma glucose (FPG) and HbA1c. This evidence concerns the gene HP and type 2 diabetes mellitus.